In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express differently between primary and metastatic tumor. | Differential expressions of PD-1 PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma